Dermatology Biotech Bambusa Dips 6.3% After $168.9 Million IPO
來源 Bloomberg 财经2 天前
內容摘要
This item is a 英文-language original; headline and summary shown as published.
Bambusa Therapeutics Inc. shares slipped 6.3% in its trading debut after the early-stage biotech focused on dermatology and autoimmune diseases raised $168.9 m…
本站僅提供標題與摘要索引，完整內容與版權均歸原發布方所有，請點擊原文連結閱讀。
前往原文- 所屬頻道
- 財經
- 所屬地區
- 美洲
- 原文語種
- English
- 條目編號
- business-e7acff41
Comments 0 comments
No comments yet. Be the first.